Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

United States

Research Site, Washington D.C., District of Columbia

Research Site, Miami, Florida

Research Site, Boston, Massachusetts

Research Site, St Louis, Missouri

Research Site, Durham, North Carolina

Research Site, Philadelphia, Pennsylvania

Canada

Research Site, Edmonton, Alberta

Research Site, Toronto, Ontario

Research Site, Montreal, Quebec

France

Research Site, Le Kremlin-Bicêtre

Research Site, Marseille

Research Site, Montpellier

Germany

Research Site, Bochum

Research Site, Giessen

Italy

Research Site, Catania

Research Site, Chieti

Research Site, Gallarate

Research Site, Roma

Japan

Research Site, Yokohama

South Korea

Research Site, Goyang-si

Spain

Research Site, Esplugues de Llobregat